Hermoso, May-ann L.
HRN: 22-43-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2023
CEFUROXIME 1.5GM (VIAL)
02/26/2023
02/27/2023
IV
1.5
Q8
Gor LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes